{"name":"Genethon","slug":"genethon","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AAV1-gamma-sarcoglycan vector injection","genericName":"AAV1-gamma-sarcoglycan vector injection","slug":"aav1-gamma-sarcoglycan-vector-injection","indication":"Other","status":"phase_1"},{"name":"Blood sample for immunology","genericName":"Blood sample for immunology","slug":"blood-sample-for-immunology","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"AAV1-gamma-sarcoglycan vector injection","genericName":"AAV1-gamma-sarcoglycan vector injection","slug":"aav1-gamma-sarcoglycan-vector-injection","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Blood sample for immunology","genericName":"Blood sample for immunology","slug":"blood-sample-for-immunology","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOXzdIMlZ5NnM3eUpCaVRqeUZFR3E5ZFVibHFLc3U0dVhBYS1ITkVVb2hweldtWEs5TXZHSXZtamk5TzBjMU1GVjRKYnFUU25pTHIyRzZCbUhNdURRZ2tscjRoRjNSMTQ3cFk0QUN4SU02UTd5ZHg3UWdHLUdDd2lBeFROZnVEd08xMTl3S2xqbW82SEpzN0tZSUdBMVllb09Vc1hFaW5KVEluOURzaEFsZmdHZWV2VW9BRGhGaUducFlOamZXMlRNeUtadTUwTWxxUW9ORGZoU08wdUVL?oc=5","date":"2026-01-26","type":"pipeline","source":"Business Wire","summary":"Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases - Business Wire","headline":"Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9jeHh2d1lGa0thWEZ3RjdrRzFSUFhQcGl0SzFyam9GUHZ1VGlvUFZwVF92SnJlSTBqenpzREJadnJzTy1MNXZHN2ZfcFQweVpxVG5QU1diaU5HU3dVRF9sTTVncjZTMkVBV0wwdFJ3UkhJWDU3Ri1Oal9n?oc=5","date":"2025-10-09","type":"pipeline","source":"RegMedNet","summary":"Cell Therapy Weekly: Updates From ESGCT 2025 - RegMedNet","headline":"Cell Therapy Weekly: Updates From ESGCT 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE5Obm8zSGdncTZ2MlloT0FEcjFHVHE4UjFiSElfdGczejFUNC1VcXRsdlJOM1pnX0NMeUhnakZHZDBKQ21CRHFjdVZXTEZWd2M?oc=5","date":"2024-09-13","type":"pipeline","source":"The Pharma Letter","summary":"ZipBio - The Pharma Letter","headline":"ZipBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaFVKb0l3aGhZclFKT0g4V2xWN0Z5VWFQQmJwaHRZZHFsWW9VMm9JYWx2NmYzd3ZMOUhHT0NUbjc0cUE5N2lHcmtmWWJ3X0JrMEN2dGs2VlZwd2ZpbWwydUdMNmd1enhUd2pxNmU0ZjR4bVNSYkRQSzZVSlVEOG9obW51c0tDQllnMzFDYld1MG9Id2tWelk3NWpMSGhOS0VnLXotQUtMX05lZw?oc=5","date":"2024-05-14","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon - Genetic Engineering and Biotechnology News","headline":"ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZWc4NWYzbzBKMEdvR3dqREpzbWdLX3AtdDQyU0hpUTRlODhudWtjMENWSldMZVEyZGRLZzBfc2hwcl9GVjk4UlBfaDN2MG5Rd0JIMHJXendOaUYxS004QXMzdEtoV0R5aWY0cERpc1FWd1ZadGZ4ODBFWVNBeU10TkpKRUxvYTRreXpVOTBZLThEWVhnVy1oa0dHeFMyanlqVURqVGZycmpsWEVUV2N4MG9pRm0?oc=5","date":"2022-05-17","type":"pipeline","source":"Fierce Biotech","summary":"UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events - Fierce Biotech","headline":"UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9KMVBHaVZXSWxRU1BxbDUycGhsTTUwVjNxcGpXRWREUjVxOU41bUNsaFBjUHJYcjF1RHpOY1dXY1NQRmliZWhxakFrUThjTWFVWFo3NDNqcm1tbUpDaURCTUFONGNOd0pIWDRJ?oc=5","date":"2022-03-13","type":"deal","source":"KED Global","summary":"SK acquires 70% stake in Yposkesi to jump into cell, gene CMO business - KED Global","headline":"SK acquires 70% stake in Yposkesi to jump into cell, gene CMO business","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}